Irving W. Schiller

789 total citations
36 papers, 471 citations indexed

About

Irving W. Schiller is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Irving W. Schiller has authored 36 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 6 papers in Immunology and Allergy. Recurrent topics in Irving W. Schiller's work include Asthma and respiratory diseases (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Respiratory Support and Mechanisms (8 papers). Irving W. Schiller is often cited by papers focused on Asthma and respiratory diseases (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Respiratory Support and Mechanisms (8 papers). Irving W. Schiller collaborates with scholars based in United States, Austria and Germany. Irving W. Schiller's co-authors include Francis C. Lowell, William Franklin, Alan L. Michelson, W. Franklin, Sheppard Siegal, William P. Boger, William B. Sherman, B. Rose, Meyer H. Halperin and Jochen G. Mainz and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Journal of Cystic Fibrosis.

In The Last Decade

Irving W. Schiller

35 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irving W. Schiller United States 13 241 156 61 45 40 36 471
Raymond E. Tobey United States 11 97 0.4× 63 0.4× 41 0.7× 57 1.3× 50 1.3× 19 367
Markku Turpeinen Finland 11 456 1.9× 382 2.4× 55 0.9× 98 2.2× 39 1.0× 14 681
Bülent Bozkurt Türkiye 13 245 1.0× 205 1.3× 120 2.0× 66 1.5× 53 1.3× 37 571
A. Manon Brenner United States 7 181 0.8× 187 1.2× 15 0.2× 28 0.6× 3 0.1× 12 336
Kenneth M. Kral United States 13 483 2.0× 592 3.8× 282 4.6× 30 0.7× 39 1.0× 17 700
Rodger E. Weismann United States 8 71 0.3× 218 1.4× 5 0.1× 307 6.8× 3 0.1× 14 593
Thomas R. Gravelyn United States 9 263 1.1× 117 0.8× 19 0.3× 60 1.3× 1 0.0× 9 383
B Osten Germany 12 53 0.2× 79 0.5× 3 0.0× 72 1.6× 10 0.3× 36 417
Tayfur Giniş Türkiye 15 117 0.5× 204 1.3× 230 3.8× 40 0.9× 177 4.4× 48 638
Anna Zedda Italy 11 242 1.0× 304 1.9× 10 0.2× 106 2.4× 5 0.1× 12 462

Countries citing papers authored by Irving W. Schiller

Since Specialization
Citations

This map shows the geographic impact of Irving W. Schiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irving W. Schiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irving W. Schiller more than expected).

Fields of papers citing papers by Irving W. Schiller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irving W. Schiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irving W. Schiller. The network helps show where Irving W. Schiller may publish in the future.

Co-authorship network of co-authors of Irving W. Schiller

This figure shows the co-authorship network connecting the top 25 collaborators of Irving W. Schiller. A scholar is included among the top collaborators of Irving W. Schiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irving W. Schiller. Irving W. Schiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mainz, Jochen G., Irving W. Schiller, Assen Koitschev, et al.. (2010). Sinonasal inhalation of dornase alfa reduces rhinosinusitis symptoms in CF. Results of a DBPC-cross-over study. Journal of Cystic Fibrosis. 9. S23–S23. 11 indexed citations
2.
Thaler, J., Thomas Kühr, Günther Gastl, et al.. (2008). Rekombinantes Interferon α-2c bei Ph-positiver chronischer myeloischer Leukämie: Ergebnisse einer multizentrischen Phase-II-Studie. DMW - Deutsche Medizinische Wochenschrift. 116(19). 721–728.
3.
Schiller, Irving W.. (1963). Bronchial Asthma — Views on Therapy. New England Journal of Medicine. 269(2). 94–97. 4 indexed citations
4.
Schiller, Irving W., et al.. (1962). Theophylline Glyceryl Guaiacolate (Quibron) In Bronchial Asthma. Diseases of the Chest. 42(4). 384–387. 2 indexed citations
5.
Schiller, Irving W. & Francis C. Lowell. (1959). Further Use of Color Coding in Drug Evaluations. New England Journal of Medicine. 261(10). 478–482. 6 indexed citations
6.
Franklin, William, Francis C. Lowell, Alan L. Michelson, & Irving W. Schiller. (1958). Aerosolized steroids in bronchial asthma. Journal of Allergy. 29(3). 214–221. 34 indexed citations
7.
Schiller, Irving W., Francis C. Lowell, & John E. Alman. (1958). The use of color-coded tablets in the clinical appraisal of two established bronchodilator preparations and N-[β-(10-phenothiazinyl) propyl] trimethyl-ammonium benzene chloride. Journal of Allergy. 29(4). 293–299. 1 indexed citations
8.
Schiller, Irving W. & Francis C. Lowell. (1958). An appraisal of oral and aerosolized methylphenidate hydrochloride (Ritalin) in obstructive pulmonary disease. Journal of Allergy. 29(2). 151–159. 1 indexed citations
9.
Franklin, William, Alan L. Michelson, Francis C. Lowell, & Irving W. Schiller. (1958). Bronchodilators and Corticosteroids in the Treatment of Obstructive Pulmonary Emphysema. New England Journal of Medicine. 258(16). 774–778. 32 indexed citations
10.
Michelson, Alan L. & Irving W. Schiller. (1957). The effect of ω-methoxy-poly (ethyleneoxy) ethyl p-butylaminobenzoate (tessalon) on ventilation and lung volumes. Journal of Allergy. 28(6). 514–518. 3 indexed citations
11.
12.
Franklin, W., Francis C. Lowell, Alan L. Michelson, & Irving W. Schiller. (1956). CHRONIC OBSTRUCTIVE PULMONARY EMPHYSEMA: A DISEASE OF SMOKERS. Annals of Internal Medicine. 45(2). 268–274. 59 indexed citations
13.
Franklin, William, Alan L. Michelson, Francis C. Lowell, & Irving W. Schiller. (1955). Clinical Value of a Tracing of Forced Expiration (Expirogram). New England Journal of Medicine. 253(19). 799–808. 31 indexed citations
14.
Schiller, Irving W., et al.. (1955). The effect of helium-oxygen mixtures on pulmonary function in asthmatic patients. Journal of Allergy. 26(1). 11–15. 12 indexed citations
15.
Lowell, Francis C., et al.. (1954). Clinical and laboratory estimation of the severity of bronchial asthma. Journal of Allergy. 25(1). 64–64. 2 indexed citations
16.
Boger, William P., William B. Sherman, Irving W. Schiller, Sheppard Siegal, & B. Rose. (1953). Allergic reactions to penicillin. Journal of Allergy. 24(5). 383–404. 38 indexed citations
17.
Lowell, Francis C., et al.. (1953). Change in the rate of oxygen saturation of the arterial blood associated with induced asthmatic attacks. Journal of Allergy. 24(6). 499–505. 2 indexed citations
18.
Franklin, William, et al.. (1952). Clinical studies with cortisone by mouth, cortisone by injection, and ACTH in the treatment of asthma. Journal of Allergy. 23(1). 27–31. 7 indexed citations
19.
Schiller, Irving W., et al.. (1951). Delirium and Coma Precipitated by Oxygen in Bronchial Asthma Complicated by Respiratory Acidosis. New England Journal of Medicine. 244(19). 710–714. 26 indexed citations
20.
Lowell, Francis C., et al.. (1951). Occurrence of Convulsive Seizures during Treatment of Asthma with Cortisone Acetate. New England Journal of Medicine. 244(2). 49–52. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymond E. Tobey Breakdown of academic impact, for papers by Markku Turpeinen Breakdown of academic impact, for papers by Bülent Bozkurt Breakdown of academic impact, for papers by A. Manon Brenner Breakdown of academic impact, for papers by Kenneth M. Kral Breakdown of academic impact, for papers by Rodger E. Weismann Breakdown of academic impact, for papers by Thomas R. Gravelyn Breakdown of academic impact, for papers by B Osten Breakdown of academic impact, for papers by Tayfur Giniş Breakdown of academic impact, for papers by Anna Zedda
Rankless by CCL
2026